News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Hidehito Horinouchi: Presidential 2, WCLC24 abstracts titles
Photo taken from Hidehito Horinouchi/X
Aug 14, 2024, 03:35

Hidehito Horinouchi: Presidential 2, WCLC24 abstracts titles

Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, shared on X:

“WCLC24 abstracts titles.

Presidential 2, Xiuning Le.

FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations.”

Hidehito Horinouchi

Additional information.
Source: Hidehito Horinouchi/X

cancer EGFR PACC Mutations Firmonertinib Hidehito Horinouchi NSCLC OncoDaily Oncology WCLC24 Xiuning Le
Special Coverage
Celebrities
Jan 16, 2025, 17:18
Bob Uecker Dies at 90 from Small-Cell Lung Cancer
Insight
Jan 16, 2025, 16:45
The 2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
Insight
Jan 16, 2025, 16:28
ACS CAN Report: High Costs Block Critical Follow-Up Tests for Breast Cancer
Blog
Jan 16, 2025, 16:20
Genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC - ASGO Education
Science
Jan 16, 2025, 16:10
Neoadjuvant therapy in patients with left-sided resectable pancreatic cancer
Blog
Jan 16, 2025, 16:05
David Wakeling: Alice’s Arc’s new research grant to some of the best minds in US paediatric cancer research
Science
Jan 16, 2025, 16:03
Estela Rodriguez: Updated analysis of CM816
Blog
Jan 16, 2025, 16:01
Elizabeth Ugwoma Awo-Ejeh: The Power of Showing Up - Closing the 10-Day Challenge
Career
Jan 16, 2025, 15:57
Elene Mariamidze: I finally got into the 2025 IASLC Academy
Insight
Jan 16, 2025, 15:50
The Gynaecology Course at the 17th BGICC
Insight
Jan 16, 2025, 15:49
Elvina Almuradova: Delighted to continue serving as a ESO Ambassador for Turkey
Blog
Jan 16, 2025, 15:46
Roupen Odabashian: Why do I see more young patients with cancer?